EW

Q: What is the price of Edwards Lifesciences (EW) today?

The price of Edwards Lifesciences (EW) today is R$ 441,30, with a variation of 16.72% compared to the last year. The price of Edwards Lifesciences (EW) started the year trading around R$ 401,98 and today it is at R$ 441,30. Follow the real-time price chart, the historical price of Edwards Lifesciences (EW), and stock data from Ibovespa and international markets.

Q: When does Edwards Lifesciences (EW) pay dividends?

Edwards Lifesciences (EW) did not distribute dividends in the last year.

Q: Edwards Lifesciences (EW) is it worth it?

Currently, Edwards Lifesciences (EW) is priced at R$ 441,30, with a P/E of 11,45%, representing a deviation of 27,73% from its historical average P/E. In the last year, the stock showed a variation of 16.72% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 16,72%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Edwards Lifesciences (EW)?

Investing in shares of Edwards Lifesciences (EW) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Edwards Lifesciences (EW) yield today?

The yield of Edwards Lifesciences (EW) was 1,59% in the last month, 16,72% in the last year and -3,63% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Edwards Lifesciences (EW) today, the total investment would be based on the current price of R$ 441,30.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 51.508,08In 5 years: R$ 42.527,71In 10 years: 152.741,41It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Edwards Lifesciences Corp.

Price

US$ 81,27

variation (12m)

16,72%

p/l

11,45

p/vp

4,48

DIVIDEND YIELD

0,00%

quote EW

BVMF

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of EW

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

1,59%

3 months

6,01%

1 year

16,72%

2 years

6,89%

5 years

-3,63%

10 years

246,12%

real profitability

profitability minus inflation.

1 month

1,59%

3 months

5,48%

1 year

10,90%

2 years

-2,57%

5 years

-29,58%

10 years

105,19%

Indicators EW

check out the fundamentals of Edwards Lifesciences shares

P/L

11,45

Sector: -1,52 Industry: -0,64

P/SALES (PSR)

8,35

Sector: 1,99 Industry: 2,47

P/VP

4,48

Sector: 2,15 Industry: 2,53

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

30,72%

Sector: -26,55% Industry: -23,60%

ROE

39,07%

Sector: -31,30% Industry: -31,85%

ROIC

17,19%

Sector: -404,40% Industry: -83,36%

Net Margin

72,90%

Sector: -26,56% Industry: -27,22%

GROSS MARGIN

78,87%

Sector: 44,49% Industry: 50,40%

OPERATING MARGIN

27,94%

Sector: -23,10% Industry: -24,81%

P/EBITDA

25,97

Sector: 0,07 Industry: 1,08

P/EBIT

28,32

Sector: -1,37 Industry: -0,61

P/ASSETS

3,52

Sector: 1,21 Industry: 1,34

VPA

18,07

Sector: 3,59 Industry: 4,65

LPA

7,06

Sector: -0,80 Industry: -0,76

EQUITY / ASSETS

0,79

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

5,32%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

38,15%

Sector: - Industry: -

FAIR PRICE OF Edwards Lifesciences ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 81,27

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-34,08%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

EW indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
LLY	45,25	34,03	75,21%	0,81%	US$ 624,41 B	25,91%
ISRG	65,56	9,52	14,52%	0,00%	US$ 170,94 B	28,51%
TMO	28,71	3,73	13,01%	0,33%	US$ 189,00 B	15,24%
MDT	25,50	0,00	0,00%	3,03%	US$ 118,85 B	13,63%
SNY	11,17	1,55	13,90%	4,31%	US$ 125,86 B	14,83%
CVS	19,92	1,16	5,84%	3,73%	US$ 90,27 B	1,17%
GSK	17,94	4,15	23,12%	4,04%	US$ 80,77 B	10,87%
ABT	15,66	4,31	27,50%	1,81%	US$ 218,97 B	32,43%
NVS	18,12	5,88	32,47%	3,05%	US$ 247,36 B	24,74%
TMDX	56,86	12,81	22,53%	0,00%	US$ 4,07 B	13,49%
HCA	16,35	-78,84	-482,31%	0,68%	US$ 97,60 B	8,21%
BSX	62,73	6,94	11,06%	0,00%	US$ 157,13 B	13,54%
INMD	5,22	1,48	28,44%	0,00%	US$ 933,03 M	44,50%
DHR	44,49	2,90	6,52%	0,56%	US$ 151,86 B	14,21%
IDXX	52,40	35,40	67,57%	0,00%	US$ 51,64 B	24,41%
FMS	20,59	0,91	4,42%	3,07%	US$ 15,03 B	3,41%
HUM	23,00	1,98	8,61%	1,18%	US$ 36,24 B	1,28%
PHG	127,59	2,23	1,75%	3,13%	US$ 26,81 B	1,07%
DXCM	56,42	12,53	22,21%	0,00%	US$ 32,25 B	13,29%

comparison of EW with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history EW dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Edwards Lifesciences

Edwards Lifesciences Corp.

Average user rating I10

4.0 (10 people)

Estados Unidos

26 years

Foundation: 1999

2000

Year of debut on the stock exchange - 25 years

14.900

Employees

The Company Edwards Lifesciences Corp. (Estados Unidos), is listed on NYSE with a market value of $ 47,46 Billions, having a net worth of $ 10,61 Billions.

With a total of 14.900 employees, the company is listed in the sector of Saúde and categorized in industry of Materiais e Equipamentos Médicos.

In the last 12 months the Company had a revenue of $ 5,69 Billions, which generated a profit in the amount of $ 4,14 Billions.

As for its main indicators, the Company has a P/E ratio of 11,45, a P/B ratio of 4,48 and in the last 12 months the Company did not pay dividends.

The Company is traded in Brazil through the BDR E1WL34, or can be purchased on abroad through the ticker EW.

Market value

US$ 47,46 Billions

Net worth

US$ 10,61 Billions

US$ 10.606.500.000,00

Assets

US$ 13,49 Billions

US$ 13.488.700.000,00

Total Number of Shares

587,00 Milhões

587.000.000

Average Daily Trading Volume

US$ 4,32 Milhões

US$ 4.322.590,44

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

EW revenue and profits

EW results

DRAG THE FRAME TO SEE MORE DATA

EW cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 27,48% (12M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,20% (12M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,10% (12M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,21% (12M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,65% (12M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --21,87% (12M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 27,48% (12 M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,20% (12 M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,10% (12 M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,21% (12 M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,65% (12 M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12 M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --21,87% (12 M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

Common Questions

What is the price of Edwards Lifesciences (EW) today?

The price of Edwards Lifesciences (EW) today is R$ 441,30, with a variation of 16.72% compared to the last year. The price of Edwards Lifesciences (EW) started the year trading around R$ 401,98 and today it is at R$ 441,30. Follow the real-time price chart, the historical price of Edwards Lifesciences (EW), and stock data from Ibovespa and international markets.

When does Edwards Lifesciences (EW) pay dividends?

Edwards Lifesciences (EW) did not distribute dividends in the last year.

Edwards Lifesciences (EW) is it worth it?

Currently, Edwards Lifesciences (EW) is priced at R$ 441,30, with a P/E of 11,45%, representing a deviation of 27,73% from its historical average P/E. In the last year, the stock showed a variation of 16.72% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 16,72%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Edwards Lifesciences (EW)?

Investing in shares of Edwards Lifesciences (EW) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Edwards Lifesciences (EW) yield today?

The yield of Edwards Lifesciences (EW) was 1,59% in the last month, 16,72% in the last year and -3,63% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Edwards Lifesciences (EW) today, the total investment would be based on the current price of R$ 441,30.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 51.508,08
In 5 years: R$ 42.527,71
In 10 years: 152.741,41

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

EW

Edwards Lifesciences Corp.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of EW

check out the fundamentals of Edwards Lifesciences shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Edwards Lifesciences

Edwards Lifesciences Corp.

Estados Unidos

26 years

2000

14.900

PROFIT X PRICE EW

EW results

EW cash flow

evolution of assets - EW

EW balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80